SCHEMBL13698127

SCHEMBL13698127

Cc1nccc(NCCCN2CCOCC2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
CYP3A4 P08684 6/20 0.58
CYP2D6 P10635 6/20 0.58
CYP1A2 P05177 5/20 0.58
CLK4 Q9HAZ1 3/20 0.58
LMNA P02545 3/20 0.58
ALOX15 P16050 3/20 0.58
CYP2C19 P33261 5/20 0.58
HSD17B10 Q99714 4/20 0.58
HIF1A Q16665 2/20 0.58
TSHR P16473 2/20 0.58
KDM4E B2RXH2 4/20 0.54
HPGD P15428 2/20 0.54
MAPT P10636 1/20 0.54
TLR9 Q9NR96 1/20 0.53
NPC1 O15118 1/20 0.50
GLA P06280 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
RAD52 P43351 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4085131 0.84 CYP3A4 (0.58) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL14641717 0.82 LMNA (0.51) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL427012 0.82 ALDH1A1 (0.58) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL3322382 0.81 KDM4E (0.53) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL11988213 0.77 DRD2 (0.57) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL2831921 0.76 ABL1 (0.49) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL12015770 0.76 ABL1 (0.47) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL11988642 0.76 FGFR1 (0.49) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL14068215 0.76 CYP1A2 (0.60) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4
SCHEMBL15260237 0.76 CYP1A2 (0.67) ALDH1A1CYP3A4CYP2D6CYP1A2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227586-A1 2-ANILINO-4-(HETEROCYCLIC)AMINO-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227586-A1 2-ANILINO-4-(HETEROCYCLIC)AMINO-PYRIMIDINES PRKCA, PRKCG, PRKCH ALDH1A1 4216/4885CYP3A4 3766/4885CYP2D6 3799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.